Valuation: Recordati

Market Cap 10.79B 12.38B 10.19B 9.25B 17.34B 1,188B 17.41B 122B 47.11B 604B 46.5B 45.47B 1,943B P/E 2026 *
21.4x
P/E 2027 * 17.4x
Enterprise Value 12.56B 14.4B 11.86B 10.77B 20.18B 1,382B 20.26B 142B 54.82B 703B 54.1B 52.9B 2,261B EV / Sales 2026 *
4.5x
EV / Sales 2027 * 4.04x
Free-Float
50.46%
Yield 2026 *
2.89%
Yield 2027 * 3.19%
1 week+1.54%
Current month+0.48%
1 month+0.38%
3 months+4.34%
6 months+16.82%
Current year+8.97%
1 week 52.25
Extreme 52.25
52.95
1 month 51.8
Extreme 51.8
53.2
Current year 43.98
Extreme 43.98
53.65
1 year 43.98
Extreme 43.98
54.2
3 years 43.46
Extreme 43.46
60.25
5 years 35.21
Extreme 35.21
60.25
10 years 27.59
Extreme 27.59
60.25
Manager TitleAgeSince
Chief Executive Officer 64 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 54 01/12/2021
Chairman 57 12/06/2018
Director/Board Member 53 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.54% - - 12.4B
+0.04%+3.34%+51.12%+101.82% 1,027B
-0.09%+1.66%+55.02%+66.18% 651B
-0.02%+2.66%+18.91%+71.47% 467B
-1.22%+3.27%+37.02%+36.52% 350B
-0.79%+2.64%+19.18%+24.76% 268B
+0.58%+6.31%+9.69%+14.26% 257B
+1.55%+2.20%+39.81%+46.55% 205B
+0.79%-1.66%-23.80%-57.76% 190B
-0.52%+4.45%+32.12%+98.51% 187B
Average +0.18%+2.49%+26.56%+44.70% 400.23B
Weighted average by Cap. +0.23%+2.62%+35.37%+61.39%

Financials

2026 *2027 *
Net sales 2.79B 3.2B 2.64B 2.39B 4.49B 307B 4.5B 31.58B 12.19B 156B 12.03B 11.76B 503B 3.03B 3.47B 2.86B 2.6B 4.86B 333B 4.88B 34.25B 13.22B 169B 13.04B 12.75B 545B
Net income 570M 654M 538M 489M 916M 62.75B 920M 6.45B 2.49B 31.9B 2.46B 2.4B 103B 684M 785M 646M 587M 1.1B 75.28B 1.1B 7.74B 2.99B 38.27B 2.95B 2.88B 123B
Net Debt 1.77B 2.02B 1.67B 1.51B 2.84B 194B 2.85B 19.97B 7.71B 98.77B 7.61B 7.44B 318B 1.45B 1.66B 1.37B 1.24B 2.33B 160B 2.34B 16.42B 6.34B 81.21B 6.25B 6.11B 261B
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
4,654
Date Price Change
18/09/26 €52.85 0.00%
17/09/26 €52.85 +0.28%
16/09/26 €52.70 +0.19%
15/09/26 €52.60 +0.48%
14/09/26 €52.35 +0.48%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
52.70EUR
Average target price
60.10EUR
Spread / Average Target
+14.04%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!